Understanding HPLC Peptide Purity Testing

What is HPLC?

High-performance liquid chromatography, abbreviated to HPLC, is an analytical technique used to separate components in a sample.

A dissolved sample is introduced into a flowing mobile phase and passed through a column containing a stationary phase. Components travel through the system at different rates because they interact differently with the mobile phase and stationary phase.

The separated components are detected as they leave the column.

For many synthetic peptides, reversed-phase HPLC is commonly used. Separation is influenced by factors that can include:

• peptide hydrophobicity;
• stationary-phase chemistry;
• mobile-phase composition;
• gradient conditions;
• pH;
• temperature;
• flow rate;
• column dimensions;
• particle characteristics.

The result belongs to the specific method used. A percentage cannot be interpreted properly without its analytical context.

What does a chromatogram show?

An HPLC chromatogram usually plots:

• time on the horizontal axis;
• detector response on the vertical axis.

Each detected component may appear as a peak.

Important chromatogram information includes:

• sample identity;
• acquisition date;
• method;
• retention time;
• peak area;
• peak height;
• integration boundaries;
• total run time;
• detector settings;
• system-suitability results.

The retention time is the time taken for a detected component to pass through the system under the stated conditions.

Retention time can support comparison with a reference, but retention time alone is not definitive molecular identification.

What does HPLC area percentage mean?

A common purity calculation compares the integrated area of the principal peak with the total integrated area of detected peaks.

A simplified expression is:

main peak area ÷ total integrated peak area × 100

The result is often described as area percentage or chromatographic purity.

This calculation depends on assumptions and method performance, including:

• relevant impurities are detected;
• peaks are adequately separated;
• integration is appropriate;
• detector responses are meaningful;
• the run is long enough to capture relevant components;
• the sample and method are suitable;
• co-eluting compounds are not hidden inside the main peak.

The EMA specifically identifies co-eluting peptide impurities as a risk and states that additional independent methods may be necessary when one method cannot adequately separate the impurity profile.^[1]

What HPLC purity does not prove

An HPLC purity result does not independently prove:

• molecular identity;
• amino-acid sequence;
• absolute peptide content;
• quantity per vial;
• water content;
• counter-ion content;
• residual-solvent content;
• elemental-impurity levels;
• sterility;
• bacterial endotoxin level;
• microbiological purity;
• long-term stability;
• suitability for human or veterinary use.

The EMA treats identity, purity and assay or content as separate specification attributes.^[1]

Why identity requires complementary evidence

A principal HPLC peak may be consistent with the expected material, but another compound could potentially have similar chromatographic behaviour.

Complementary methods may include:

• mass spectrometry;
• LC-MS;
• peptide mapping;
• amino-acid analysis;
• nuclear magnetic resonance;
• comparison with a qualified reference standard.

Mass spectrometry can provide evidence regarding molecular mass and, depending on the experiment, amino-acid sequence or structural fragments.

The EMA recommends using at least two suitable orthogonal approaches for unambiguous peptide identification.^[1]

Why the method matters

Two laboratories may report different purity results for the same material if their methods differ in:

• column;
• gradient;
• mobile phase;
• detector;
• wavelength;
• temperature;
• sample concentration;
• integration;
• run time;
• impurity resolution.

That does not necessarily mean that one result is fraudulent. It means the analytical conditions and validation must be understood before comparing numbers.

System suitability

System suitability checks whether the chromatographic system is performing adequately for the analysis.

Depending on the procedure, this may evaluate:

• repeatability;
• resolution;
• peak symmetry;
• retention consistency;
• detector sensitivity;
• theoretical plates;
• relative standard deviation.

A chromatogram without suitable system performance may not support a reliable result.

USP General Chapter <621> describes general chromatographic requirements and system-suitability principles used in compendial procedures.^[2]

A practical HPLC review checklist

When reviewing a peptide HPLC report, look for:

1. Product and batch identification
2. Laboratory sample number
3. Test and acquisition date
4. Method or procedure reference
5. Column information
6. Mobile phases and gradient
7. Detector settings
8. Full chromatogram
9. Complete peak table
10. Main-peak retention time
11. Individual impurity areas
12. Total integrated area
13. Integration parameters
14. System-suitability results
15. Specification
16. Reported result
17. Authorised sign-off
18. Complementary identity result